当前位置:首页 - 行情中心 - 信隆健康(002105) - 财务分析 - 现金流量表

信隆健康

(002105)

  

流通市值:19.65亿  总市值:19.74亿
流通股本:3.64亿   总股本:3.66亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,157,095,906.03762,427,727.51390,914,330.931,282,648,175.67
  收到的税费返还35,307,394.5614,843,322.572,895,587.931,810,825.69
  收到其他与经营活动有关的现金35,296,741.7335,841,814.964,805,727.2322,055,805.17
  经营活动现金流入小计1,227,700,042.32813,112,865.04398,615,646.061,336,514,806.53
  购买商品、接受劳务支付的现金888,215,514.34575,050,058.54297,359,184.12934,419,819.42
  支付给职工以及为职工支付的现金209,536,940.42142,225,500.3772,688,646.51260,946,381.12
  支付的各项税费15,588,711.9911,950,651.454,445,709.0324,308,735.59
  支付其他与经营活动有关的现金36,216,004.7224,456,213.169,793,407.6659,445,000.58
  经营活动现金流出小计1,149,557,171.47753,682,423.52384,286,947.321,279,119,936.71
  经营活动产生的现金流量净额78,142,870.8559,430,441.5214,328,698.7457,394,869.82
二、投资活动产生的现金流量:
  收回投资收到的现金---85,038.98
  处置固定资产、无形资产和其他长期资产收回的现金净额6,433,152.554,746,821.52333,983.934,149,834.46
  收到的其他与投资活动有关的现金---13,903,318.57
  投资活动现金流入小计6,433,152.554,746,821.52333,983.9318,138,192.01
  购建固定资产、无形资产和其他长期资产支付的现金41,207,558.7731,108,584.4313,420,435.0379,387,407.3
  支付其他与投资活动有关的现金---13,829,436.03
  投资活动现金流出小计41,207,558.7731,108,584.4313,420,435.0393,216,843.33
  投资活动产生的现金流量净额-34,774,406.22-26,361,762.91-13,086,451.1-75,078,651.32
三、筹资活动产生的现金流量:
  吸收投资收到的现金---15,000
  其中:子公司吸收少数股东投资收到的现金---15,000
  取得借款收到的现金352,450,229.73252,613,509.51123,005,698.52485,835,958.07
  筹资活动现金流入小计352,450,229.73252,613,509.51123,005,698.52485,850,958.07
  偿还债务支付的现金388,267,403.48265,039,740.5678,756,464.34480,113,132.72
  分配股利、利润或偿付利息支付的现金10,922,030.587,567,409.053,607,623.4916,640,202.06
  支付其他与筹资活动有关的现金8,864,786.357,145,819.974,413,589.8911,972,268.19
  筹资活动现金流出小计408,054,220.41279,752,969.5886,777,677.72508,725,602.97
  筹资活动产生的现金流量净额-55,603,990.68-27,139,460.0736,228,020.8-22,874,644.9
四、汇率变动对现金及现金等价物的影响-17,219,528.69-13,167,467.38-2,839,976.96-3,630,428.58
五、现金及现金等价物净增加额-29,455,054.74-7,238,248.8434,630,291.48-44,188,854.98
  加:期初现金及现金等价物余额339,264,279.09339,264,279.09339,264,279.09383,453,134.07
  期末现金及现金等价物余额309,809,224.35332,026,030.25373,894,570.57339,264,279.09
补充资料:
  净利润-6,735,973.37--67,893,521.67
  资产减值准备-2,102,022.57-33,850,909.56
  固定资产和投资性房地产折旧-34,488,015.27-75,085,657.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-34,488,015.27-75,085,657.62
  无形资产摊销-2,348,690.75-4,568,741.92
  长期待摊费用摊销-146,058.88-214,777.84
  处置固定资产、无形资产和其他长期资产的损失-474,814.71--34,776.61
  固定资产报废损失--458,536.37-2,099,179.73
  公允价值变动损失-0-0
  财务费用-21,208,205.52-19,275,312.64
  投资损失-3,631,921.46-3,973,855.94
  递延所得税-216,146.02--5,426,102.35
  其中:递延所得税资产减少-962,557.07--5,234,691.3
    递延所得税负债增加--746,411.05--191,411.05
  存货的减少--1,405,445.19-1,230,990.29
  经营性应收项目的减少--1,563,410.43--27,077,062.77
  经营性应付项目的增加--11,562,212.36-2,467,542.48
  其他---2,150,261.41
  现金的期末余额-332,026,030.25-339,264,279.09
  减:现金的期初余额-339,264,279.09-383,453,134.07
  现金及现金等价物的净增加额--7,238,248.84--44,188,854.98
公告日期2026-10-242026-08-222026-04-292026-04-24
审计意见(境内)标准无保留意见
TOP↑